StrainX Bioworks raises $13 million led by Prime Venture, Leo Capital
StrainX Bioworks, a synthetic biology startup, has secured $13 million in Series A funding. Prime Venture Partners and Leo Capital led the round. The company plans to expand research and development, scale fermentation infrastructure, and accelerate commercialization. StrainX focuses on food, nutraceuticals, and personal care industries. It has demonstrated fermentation at the 10,000-litre scale and is working towards larger capacities.
StrainX Bioworks, a synthetic biology startup, has secured $13 million in Series A funding. Prime Venture Partners and Leo Capital led the round. The company plans to expand research and development, scale fermentation infrastructure, and accelerate commercialization. StrainX focuses on food, nutraceuticals, and personal care industries. It has demonstrated fermentation at the 10,000-litre scale and is working towards larger capacities.
